Transitioning individuals with peanut allergy from US Food and Drug Administration-approved peanut oral immunotherapy to a dietary peanut product
Department
Allergy and Immunology
Document Type
Article
Publication Title
Annals of Allergy, Asthma & Immunology
First Page
113
Last Page
114
DOI
10.1016/j.anai.2022.09.037
Volume
130
Issue
1
Publication Date
1-1-2023
PubMed ID
36210007
Recommended Citation
Mustafa, S. S., & Shroba, J. (2023). Transitioning individuals with peanut allergy from US Food and Drug Administration-approved peanut oral immunotherapy to a dietary peanut product. Annals of Allergy, Asthma & Immunology, 130 (1), 113-114. https://doi.org/10.1016/j.anai.2022.09.037
COinS